|
| General category interpretation | Number of cases (%) | Sex (M/F) | Median age (years) | TIC + SP + biopsy/only biopsy/cytology (%) | Correct diagnosis; misdiagnoses/accuracy = n |
|
| A-neoplastic-primary tumors | | | | | |
| A.1-Glial/glioneural tumors or lesions | — | 32/16 | 48.8 (±20.8) | 37 (77.1)/11 (22.9) | — |
| Glioblastoma, IDH-wild type, Grade 4 | 24 (16.7) | — | — | — | 1/15 |
| Astrocytoma, IDH-mutant, Grade 4 | 1 (0.7) | — | — | — | — |
| Astrocytoma, IDH-mutant, Grade 2 | 3 (2.1) | — | — | — | 0/3 |
| Astrocytoma, Grade 2 | 7 (4.9) | — | — | — | 0/7 |
| Pilocytic astrocytoma, Grade 1 | 4 (2.8) | — | — | — | 0/4 |
| Oligodendroglioma, IDH-mutant, Grade 3 | 2 (1.4) | — | — | — | 0/2 |
| Pediatric-type diffuse high-grade gliomas | 1 (0.7) | — | — | — | — |
| Spinal ependymoma | 1 (0.7) | — | — | — | 0/1 |
| Supratentorial ependymoma, Grade 3 | 1 (0.7 | — | — | — | 0/1 |
| Gliosis | 2 (1.4) | — | — | — | 0/1 |
| Radiation-induced change | 1 (0.7) | — | — | — | 0/1 |
| Cortical tubers | 1 (0.7) | — | — | — | 0/1 |
| A.2-Nonglial tumors or lesions | — | 20/28 | 49.9 (±19.8) | 11 (22.9)/37 (77.1) | — |
| Meningioma, meningothelial, Grade 1 | 10 (6.9) | — | — | — | 0/4 |
| Meningioma, fibrous type, Grade 1 | 5 (3.5) | — | — | — | 0/5 |
| Meningioma, psammomatous, Grade 1 | 1 (0.7) | — | — | — | 0/1 |
| Meningioma, angiomatous, Grade 1 | 2 (1.4) | — | — | — | 0/1 |
| Atypical meningioma, Grade 2 | 4 (2.8) | — | — | — | 0/4 |
| Schwannoma, Grade 1 | 4 (2.8) | — | — | — | 0/2 |
| Neurofibroma, Grade 1 | 1 (0.7) | — | — | — | 0/1 |
| Hybrid nerve sheath tumor, Grade 1 | 1 (0.7) | — | — | — | 0/1 |
| Hemangioblastoma, Grade 1 | 2 (1.4) | — | — | — | 1/0 |
| Pituitary adenoma | 10 (6.9) | — | — | — | 0/1 |
| Pituitary apoplexy | 2 (1.4) | — | — | — | 0/1 |
| Hydatid cyst | 1 (0.7) | — | — | — | 0/1 |
| Hemangioma | 2 (1.4) | — | — | — | 0/1 |
| Medulloblastoma, non-WNT/non-SHH, Grade 4 | 1 (0.7) | — | — | — | — |
| Embryonal tumor with multilayered rosettes, Grade 4 | 1 (0.7) | — | — | — | 0/1 |
| Atypical teratoid/rhabdoid tumor, Grade 4 | 1 (0.7) | — | — | — | — |
| B-Neoplastic-metastatic tumors | — | 32/16 | 55.4 (±13.6) | 31 (64.6)/15 (31.3)/2 (4.2) | — |
| Metastatic lung carcinomas | 19 (13.2) | — | — | — | 0/14 |
| Metastatic breast carcinoma | 8 (5.6) | — | — | — | 0/3 |
| Metastatic colorectal carcinomas | 3 (2.1) | — | — | — | 0/2 |
| Metastatic (other) gastrointestinal carcinomas | 3 (2.1) | — | — | — | 0/3 |
| Metastatic clear cell renal cell carcinomas | 1 (0.7) | — | — | — | 0/1 |
| Metastatic thyroid carcinomas | 2 (1.4) | — | — | — | 0/1 |
| Metastatic ovarian carcinomas | 2 (1.4) | — | — | — | 0/1 |
| Metastatic carcinoma of unknown primary | 1 (0.7) | — | — | — | — |
| Metastatic melanoma | 2 (1.4) | — | — | — | — |
| Hematolymphoid neoplasm | 6 (4.1) | — | — | — | 3/2 |
| Metastatic sarcomas | 1 (0.7) | — | — | — | 0/1 |
| Total cases | 144 (100) | — | — | — | 5/88 |
|
